Aprecia Pharmaceuticals

View the org chart displaying its 9 main executives

Most searched biographies at Aprecia Pharmaceuticals

• Owen Murray, Chief Executive Officer
• Thomas Arington, Chairman of the Board
• Kathi Rinesmith, Senior Vice President, Regulatory Affairs

Popular executive movements at Aprecia Pharmaceuticals

• Andrew Karazim has joined the company as Chief Commercial Officer  (posted on February 8 2024).

Create your alert
to follow the executive moves at Aprecia Pharmaceuticals.

Aprecia Pharmaceuticals has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Aprecia Pharmaceuticals

• Aprecia Names Andrew Karazim as New Chief Commercial Officer
• Aprecia and Battelle Are Impacting The Pharmaceutical Industry Through 3D Printing Innovation

Social media about Aprecia Pharmaceuticals

• Aprecia Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Aprecia Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Owen Murray

Call Aprecia Pharmaceuticals at +1 513...

View the org chart

Register to receive your alert

Report an error